Cite
Hey JA, Kocis P, Hort J, et al. Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain. CNS Drugs. 2018;32(12):1185doi: 10.1007/s40263-018-0585-6.
Hey, J. A., Kocis, P., Hort, J., Abushakra, S., Power, A., Vyhnálek, M., Yu, J. Y., & Tolar, M. (2018). Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain. CNS drugs, 32(12), 1185. https://doi.org/10.1007/s40263-018-0585-6
Hey, John A, et al. "Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain." CNS drugs vol. 32,12 (2018): 1185. doi: https://doi.org/10.1007/s40263-018-0585-6
Hey JA, Kocis P, Hort J, Abushakra S, Power A, Vyhnálek M, Yu JY, Tolar M. Correction to: Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain. CNS Drugs. 2018 Dec;32(12):1185. doi: 10.1007/s40263-018-0585-6. PMID: 30421245; PMCID: PMC6828218.
Copy
Download .nbib